Cerebrovascular disease.
D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000517:prevention & control; D014057:Tomography, X-Ray Computed
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D001241:Aspirin; D013442:Sulfinpyrazone